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Abstract
Background: People of different racial and ethnic backgrounds have a distinct pattern of central fat deposition,
thus making it necessary to devise a race based approach for the diagnosis and evaluation of abdominal obesity
(AO). This is the first study to determine the optimal waist circumference (WC) cutoff values for definition of AO in
an ethnic Kyrgyz population.
Methods: 323 persons of Kyrgyz ethnicity (183 women and 140 men), with a mean age of 51.8 ± 9.5 years old
were included in the study. Measurement of blood pressure (BP), anthropometric data (including body mass index
calculation and WC measurement), fasting blood sugar, serum lipid parameters and insulin were performed in all
examined individuals. Insulin resistance (IR) was considered as HOMA index (insulin × fasting glucose/22.5) ≥ 2.77.
Sensitivity and specificity for the presence of IR or two other criteria of MS (according to the international
classification, 2009) were calculated by using receiver operating characteristic (ROC) curves for men and women
separately.
Results: The optimal sensitivity and specificity obtained from the ROC curves for IR were 88 cm in women
(sensitivity of 0.85, 95%CI (0.72-0.93), specificity of 0.58, 95%CI (0.49-0.66)) and 94 cm for men (sensitivity of 0.8, 95%
CI (0.65-0.91), specificity of 0.61, 95% CI (0.51-0.71)). The data from the ROC curve for any two other MS criteria
confirmed the results and the WC 88 cm in women (sensitivity of 0.82, 95% CI (0.72-0.9), specificity of 0.72, 95% CI
(0.62-0.8)) and 94 cm in men (sensitivity of 0.74, 95% CI (0.62-0.84), specificity of 0.73, 95% CI (0.61-0.83)) were
corresponded to the optimal sensitivity and specificity.
Conclusion: WC ≥ 88 cm and ≥ 94 cm should be used as a criterion for the diagnosis of AO for Kyrgyz women
and men respectively based on these results.
Keywords: Obesity, Abdominal obesity, Waist circumference insulin resistance, Metabolic syndrome, Cardiovascular
risk
Background
Metabolic syndrome (MS) is a particularly common
medical condition consisting of abdominal obesity (AO),
arterial hypertension, as well as disturbances in lipid
and/or carbohydrate metab o l i s m .T h ep r e s e n c eo fM S
increases cardiovascular morbidity and mortality and
risk of future type 2 diabetes mellitus (DM) [1,2].
O b e s i t yi sb e l i e v e dt ob eac o r ep a t h o l o g i cs t i m u l u sf o r
the development of hyperinsulinemia and insulin resis-
tance (IR), which are predictive for the development of
new onset type 2 DM [3]. Obesity is also associated
with increased cardiovascular risk, but with age this
association seems to fade [4].
Several clinical approaches for MS diagnosis are cur-
rently available such as, Adult Treatment Panel (ATP
III) of the National Cholesterol Education Program [5]
and its modified version [6] use waist circumference
(WC) of ≥88 cm and ≥102 cm for the diagnosis of AO
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criteria are best suitable for North American population,
and the fact that people of Asian origin have higher
abdominal fat with the same body mass index (BMI) as
well as a greater risk for the new onset type 2 DM with
the same BMI values and this approach may underesti-
mate metabolic risk among Asians [7]. Dong and collea-
gues have found the greater accuracy of height to
weight ratio for the diagnosis of MS compared to tradi-
tional measurement of WC in a Chinese population [8].
Interestingly, Park and colleagues have demonstrated
that Asians with BMI < 27 kg/m2 have higher predictive
power of epicardial fat for the presence of MS and cor-
onary artery disease, which may indirectly support the
notion of distinct pattern of adiposity among Asians [9].
The controversies of current clinical models for diagnos-
ing MS were highlighted in the secondary analysis of the
FIELD study [10]. The researchers compared three differ-
ent criteria for MS: World Health Organization, ATP III
and International Diabetes Federation. They have con-
cluded that WHO MS criteria can identify patients with
DM who have a lower risk of future cardiovascular events.
There are some misconceptions regarding the optimal
WC values and methods of assessing this in some Asian
populations [11,12]. A recent Joint Interim Statement on
MS proposes that WC ≥80 cm and ≥90 cm are diagnostic
for AO in Asian women and men respectively [13]. How-
ever such generalization may be wrong due to possible
heterogeneities among Asian populations. Thus, the need
for different diagnostic criteria based on ethnic back-
ground was critically needed.
The information about optimal WC values for MS
diagnosis was not known for the Kyrgyz ethnic group,
and this became a cardinal impetus for the study.
Methods
Studied population
323 individuals (183 females, 140 males) 30-80 years
(mean age 51.8 ± 9.5 years) from the general population
were included in the study. Informed consent was signed
prior to enrollment. Exclusion criteria: pregnancy, conco-
mitant thyroid disease, heart failure, chronic kidney and
liver disease, insulin therapy and chronic alcohol
addiction.
Systolic and diastolic blood pressure (SBP and DBP
respectively) measurements, anthropometric assessment
such as weight, height were measured in all study partici-
pants. WC was measured in the standing relaxed position,
during expiration, at the midline between the lower costal
margins and the iliac crest parallel to the floor. Body mass
index (BMI) was calculated as a weight (kg) to height (m
2)
ratio.
The general characteristics of studied population are
present in Table 1.
Laboratory tests
Blood collection from the cubital vein took place after
12 h of fasting in the morning, with further separation to
the plasma and serum, which were frozen in liquid nitro-
gen. Subsequently laboratory tests such as fasting plasma
glucose (FPG), total cholesterol (TC), triglycerides (TG),
high density lipoprotein cholesterol (HDL-C) and immu-
noreactive insulin levels were analyzed from the frozen
blood samples. Low density lipoprotein cholesterol (LDL-
C) was calculated by Friedwald W. formula [14]. Homeos-
tasis model of assessment (HOMA) was used as a surrogate
marker of IR and calculated as serum insulin (μIU/ml) ×
plasma glucose (mmol/l)/22.5. HOMA index ≥2.77 was
considered to be diagnostic for IR, according to the results
f r o mt h eB r u n e c ks t u d y[ 1 5 ] .
Statistical analysis
The “Microsoft-Statistica 8.0” and “Graph Pad PRIZM 5”
software were used for statistical analyses. ANOVA
according to Kruskal-Wallis method was used to com-
pare the IR values (given the nonparametric distribution
of variables). A posthoc comparison of variables was
measured by the Mann-Whitney test with Bonferroni
correction. Odds ratio (OR) and 95% confidence interval
(CI) were calculated using the “2×2t a b l e s ” in the
“Graph Pad PRIZM 5” program. Receiver-Operating
Characteristic (ROC) analysis was performed with the
Table 1 General characteristics of studies population
Variables Study participants (n - 323)
Age; years 51.8 ± 9.5
AH; n (%) 133 (41.2%)
SBP: mm Hg 135.2 ± 21.8
DBP; mm Hg 85.5 ± 12.5
Obesity (BMI ≥ 30 kg/m
2); n (%) 97 (30%)
BMI; kg/m
2 27.5 ± 4.8
WC; cm 91.7 ± 11.5
Smoking; n (%) 48 (14.9%)
Positive family history for CVD; n (%) 73 (22.6%)
Type 2 DM; n (%) 25 (7.7%)
Fasting glucose; mmol/l 5.92 ± 1.83
Insulin resistance; n (%) 88 (27.2%)
Serum insulin; μIU/ml* 7.25 (4.89-10.6)
HOMA index* 1.85 (1.18-2.99)
CHD; n (%) 28 (8.7%)
TC; mmol/l 5.12 ± 1.11
HDL-C; mmol/l 1.14 ± 0.34
LDL-C; mmol/l 3.27 ± 0.96
TG; mmol/l* 1.24 (0.95-1.92)
*Data is presented as median (25%-75%); Abbreviations: AH-arterial
hypertension, BMI-body mass index, CHD-coronary heart disease, CVD -
cardiovascular diseases, DBP-diastolic blood pressure, DM- diabetes mellitus,
HDL-C-high density cholesterol, IR-insulin resistance, LDL-C-low density
cholesterol, SBP-systolic blood pressure, TC-total cholesterol, TG-triglycerides,
WC-waist circumference
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WC values. Variables are present as mean ± standard
deviation for normal distribution and median (25%-75%)
for variables with nonparametric distribution. The
p value < 0.05 was used as a cut off for statistical
significance.
Results
To define the threshold values for WC, the entire data set
(separately for men and women) was divided into sub-
groups with WC increments of 4-5 cm. Common border-
line values from the modified ATP III criteria (≥ 102 cm
in men and ≥88 cm in women), the International diabetes
Federation (IDF) criteria (≥94 cm in men and ≥80 cm in
women) and the IDF criteria for the Asian population (≥
90 cm in men and ≥80 cm in women) were taken into
consideration. Thus, women were subdivided based on the
WC values into subgroups of < 80 cm, 80-87 cm, and ≥88
cm; and men were subdivided into these subgroups < 90
cm, 90- 93 cm, 94-101 cm, ≥102 cm.
After this, each subgroup was analyzed for the presence
of IR, blood insulin concentration, the HOMA index and
the OR of having IR. A greater WC was associated with
an increased likelihood for IR in both women and men.
Women with WC ≥88 cm had 2.5 times increased preva-
lence of IR compared to the WC of 80-87 cm. 23% of
men with WC ≥90 cm had IR, whereas 28% of men with
WC of 94-101 cm had IR. 60% of men with WC ≥ 102
cm had IR, which was expected. However statistical sig-
nificance was observed only for the subgroup with WC of
94-101 cm.
The gradual statistically significant increase of HOMA
index and blood insulin concentration was found in
association with the increase in WC for all groups. Neither
m e nn o rw o m e ne x p e r i e n c e dj u m p si nH O M Ai n d e xo r
insulin concentration.
Greater OR for IR were associated with the increase in
WC. Statistically significant differences in OR for IR
were observed between the first and third women sub-
groups. Whereas differences between the first and
second women subgroups were close to statistical signif-
icance. Men had statistically significant differences in
OR for IR compared to men with WC < 90 cm. The OR
for IR increased in men with WC of 94-101 cm, but
compared to the WC of 90-93 cm the difference was
not significant (Tables 2 and 3).
During the construction of ROC curves, women with
WC of 80 cm had a sensitivity of 98%, but relatively low
specificity of 32%. Whereas women with WC of 88 cm
had specificity of 58% and sensitivity of 85% (Figure 1).
In an analogous analysis, men with WC of 90 cm had a
sensitivity of 95% and relatively low specificity of 49%.
Men with WC of 94 cm had greater specificity of 61% and
sensitivity 80%, and men with WC of 102 cm, had specifi-
city of 90%, but the sensitivity was markedly decreased
and reached 46% (Figure 2).
Current clinical guidelines do not include IR as the MS
criteria. Therefore, we alsoc o n d u c t e dR O Ca n a l y s i st o
identify the threshold WC values, which increase the risk
for detection of any two other MS criteria (BP ≥ 130/85
mm Hg, fasting blood sugar ≥ 5,6 mmol/l, HDL-C in
men < 1.03 mmol/l and in women < 1.29 mmol/l, TG 1.7
mmol/l).
The results of this analysis were almost the same as dur-
ing the ROC analysis for the IR. Thus, for women with
WC of 80 cm the sensitivity was nearly 100%, but
Table 2 IR indexes according to WC in women
Subgroups WC; cm IR; n (%) Insulin concentration
$ HOMA
$ OR (95% CI)
1 < 80 (n-41) 1(2.4) 4.49 (2.83-5.92) 1.03 (0.63-1.43) 1
2 80-87 (n-40) 6(15) 6.74* (5.39-8.41) 1.64*(1.21-1.96) 7.05(0.8-61.6) P1-2 = 0.057
3 ≥88 (n-102) 40(39)*
# 9.04*
# (7.10-14.0) 2.46*
# (1.79-3.71) 26 (3.4-19.5) P1-3 < 0.0001 P2-3 < 0.005
P < 0.00001 < 0.0001 < 0.0001
$- Data is presented as median (25%-75%);
*p < 0.0001 as compared with 1 subgroup; #p < 0.0001 as compared with 2 subgroup Abbreviations: OR-odds ratio
Table 3 IR indexes according to WC in men
Subgroups WC; cm IR; n (%) Insulin concentration
$ HOMA
$ OR (95% CI)
1 < 90 (n-44) 2 (4.2) 3.85 (2.69-6.87) 0.95 (0.65-1.65) 1
2 90-93 (n-21) 5 (23) 6.03 (5.14-7.05) 1.49 (1.30-2.08) 6.56 (1.15-3.73) P1-2 < 0.01
3 94-101 (n-35) 10 (28)* 7.41* (5.32-10.91) 1.87* (1.38-3.04) 8.4 (1.7-4.15) P1-3 < 0.003
4 ≥102 (n-40) 24 (60) *
#£ 10.7*
#£ (8.3-15.65) 3.14*
#£ (2.17-4.81) 31.5 (6.66-14.9) P1-4 < 0.0001 P2-4001 P3-4 < 0.005
P < 0.00001 < 0.0001 < 0.0001
$-Data is presented as median (25%-75%)
*P < 0.0001 as compared with 1 subgroup; #P < 0.0001 as compared with 2 subgroup; £P < 0.0001 as compared with 3 subgroup
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moderate decrement in sensitivity to 82%, and increase in
specificity to 72% (Figure 3).
In men with the WC of 90 cm a fairly high specificity
(63%) was noted, which was increased to 73% in men
with WC of 94 cm and men with WC of 102 cm had
specificity of 89%. Men with WC of 94 cm had moder-
ately decreased sensitivity of 74%, and men with WC of
102 cm experienced a sharp drop in sensitivity to 30%
(Figure 4).
Discussion
The data regarding the definition of AO based on ethnic
and racial guidelines is controversial. US Caucasians have
increased cardiovascular risk with WC ≥102 cm and ≥88
cm for men and women respectively. Whereat, African
Americans have borderline WC of 89 to 109 cm for men
and from 83 to 105 cm for women respectively, due to a
lower amount of visceral fat with the same BMI [16-18].
Since African Americans have a higher prevalence of car-
diovascular risk factors it was believed to use a similar
WC cut off. The similar conclusions were made for indi-
genous American population [19].
The same is true regarding borderline WC values for
Europeans. Accordingly to some studies, the risk of new
onset type 2 DM development increases from WC ≥94 cm
and ≥ 80 cm in men and women respectively [20-22].
The studies on Asian populations have shown that
Asians have a higher level of visceral fat within the same
BMI values compared to Caucasians [23,24].
In India, where type 2 DM and IR are highly prevalent
[24,25], the researchers have found that the risk of type
2 DM started to rise from BMI > 23 kg/m2 and WC >
85 cm in men and WC > 80 in women [26,27]. The
optimal WC values of ≥85 cm for men and ≥80 cm for
Figure 1 Sensitivity and specificity for the presence of IR
according to WC increase in women (ROC curve).
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Figure 2 Sensitivity and specificity for the presence of IR
according to WC increase in men (ROC curve).
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Figure 3 Sensitivity and specificity for detection of two MS
criteria in women (ROC curve).
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Figure 4 Sensitivity and specificity for detection of two MS
criteria in men (ROC curve).
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Page 4 of 6women of Chinese descent were found after pooling the
results of 13 population studies [28].
Similar studies were performed in Japan where bor-
derline WC values of 85 to 90 cm for men and > 80 cm
for women were found [29]. In an ethnic Korean popu-
lation, the borderline WC ranges from 85 to 90 cm in
men and from 80 to 85 cm in women [30-32]. The bor-
derline WC values of 99.5 cm for men and 94.3 cm
were found for Iranians aged 19-65 years [33].
Controversies on the optimal definition of the AO
according to the racial and ethnic background are still pre-
sent. Our data may be extrapolated on nearby Central
Asian indigenous groups, such as Kazakhs, Uzbeks and
Turkmens and help to resolve some of the current difficul-
ties in this area. Nevertheless studies with a larger popula-
tion sample are critically needed to find the optimal
d e f i n i t i o nf o rA Oi nC e n t r a lA s i a np o p u l a t i o ng r o u p s .
This approach can significantly increase the accuracy for
the diagnosis of AO, which is a key criterion for the diag-
nosis of MS. Thus it can potentially decrease the health-
care burden of this disease through appropriate lifestyle
and medical intervention in a proper time.
Conclusion
This is the first study to determine the optimal WC cut off
values for an ethnic Kyrgyz population. WC ≥ 88 cm and
≥94 cm should be used as a criterion for the diagnosis of
AO for Kyrgyz women and men respectively based on
these results.
Abbreviations
AO: Abdominal obesity; ATP: Adult treatment panel; BMI: Body mass index;
DBP: Diastolic blood pressure; DM: Diabetes mellitus; FPG: Fasting plasma
glucose; HDL-C: High density lipoprotein cholesterol; HOMA: Homeostasis
model of assessment; IDF: International diabetes federation; IR: Insulin
resistance; LDL-C: Low density lipoprotein cholesterol; MS: Metabolic
syndrome; ROC: Receiver operating characteristic; SBP: Systolic blood
pressure; TC: Total cholesterol; TG: Triglycerides; WC: Waist circumference.
Author details
1Kyrgyz State Medical Academy named by I.K. Akhunbaev, Akhunbaev street
92, Bishkek 720020, Kyrgyzstan.
2National Centre of Cardiology and Internal
medicine named by M. Mirrakhimov, T. Moldo 3, Bishkek 720040, Kyrgyzstan.
Authors’ contributions
All authors contributed equally in the patient evaluation and article draft
composition. AEM and OSL performed statistical analysis of the data. EMM
edited the manuscript for content and AEM revised it and translated into
English. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 5 December 2011 Accepted: 22 February 2012
Published: 22 February 2012
References
1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpussalo E,
Tuomilehto J, Salonen JT: The metabolic syndrome and total and
cardiovascular disease mortality in middleaged men. JAMA 2002,
288:2709-2716.
2. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Folsom AR,
Chambless LE: Identifying individuals at high risk for diabetes: The
Atherosclerosis Risk in Communities study. Diabetes Care 2005,
28:2013-2018.
3. Sung KC, Seo MH, Rhee EJ, Wilson AM: Elevated fasting insulin predicts
the future incidence of metabolic syndrome: a 5-year follow-up study.
Cardiovasc Diabetol 2011, 10:108.
4. Wakabayashi I, Daimon T: Receiver-operated characteristics (ROCs) of the
relationships between obesity indices and multiple risk factors (MRFs)
for atherosclerosis at different ages in men and women. Arch Gerontol
Geriatr 2011.
5. National Cholesterol Education Program (NCEP) Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III). Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and reatment of High Blood Cholesterol in Adults (Adult
Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA,
Gordon DJ, et al: Diagnosis and management of the metabolic
syndrome: an American Heart Association/National Heart, Lung and
Blood Institute scientific statement. Curr Opin Cardiol 2006, 21:1-6.
7. Alberti KG, Zimmet P, Shaw J: IDF Epidemiology Task Force Consensus
Group. The metabolic syndrome: a new worldwide definition. Lancet
2005, 366:1059-1062.
8. Dong X, Liu Y, Yang J, Sun Y, Chen L: Efficiency of anthropometric
indicators of obesity for identifying cardiovascular risk factors in a
Chinese population. Postgrad Med J 2011, 87:251-256.
9. Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS,
Tahk SJ, Shin JH: Impact of body mass index on the relationship of
epicardial adipose tissue to metabolic syndrome and coronary artery
disease in an Asian population. Cardiovasc Diabetol 2010, 9:29.
10. Scott R, Donoghoe M, Watts GF, O’Brien R, Pardy C, Taskinen MR, Davis TM,
Colman PG, Manning P, Fulcher G, Keech AC: Impact of metabolic
syndrome and its components on cardiovascular disease event rates in
4900 patients with type 2 diabetes assigned to placebo in the FIELD
randomised trial. Cardiovasc Diabetol 2011, 10(1):102.
11. Yokoyama H, Hirose H, Kanda T, Kawabe H, Saito I: Relationship between
waist circumferences measured at the umbilical level and midway
between the ribs and iliac crest - a solution to the debate on optimal
waist circumference standards in the diagnostic criteria of metabolic
syndrome in Japan. J Atheroscler Thromb 2011, 18:735-743.
12. Das M, Pal S, Ghosh A: Prevalence of the metabolic syndrome in people
of Asian Indian origin: outcomes by definitions. Cardiovasc J Afr 2011,
22:303-305.
13. Alberti MM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KI, et al:
Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the
Association for the Study of Obesity Heart Federation; International
Atherosclerosis Society; and International National Heart, Lung, and
Blood Institute; American Heart Association; World International
Diabetes Federation Task Force on Epidemiology and Prevention.
Circulation 2009, 120:1640-1645.
14. Fridewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of
low density lipoprotein cholesterol in plasma, without use of the
preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
15. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G,
Alberiche M, Bonadonna RC, Muggeo M: Prevalence of insulin resistance
in metabolic disorders: the Bruneck Study. Diabetes 1998, 47:1643-1649.
16. Deurenberg P, Yap M, van Staveren WA: Body mass index and percent
body fat: a meta-analysis among different ethnic groups. Int J Obes Relat
Metab Disord 1998, 22:1164-1171.
17. Diaz VA, Mainous AG III, Baker R, Carnemolla M, Majeed A: How does
ethnicity affect the association between obesity and diabetes? Diabet
Med 2007, 24(11):1199-1204.
18. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S: Race-
ethnicity-specific waist circumference cutoffs for identifying
cardiovascular disease risk factors. Am J Clin Nutr 2005, 81:409-415.
19. Lear SA, James PT, Ko GT, Kumanyika S: Appropriateness of waist
circumference and waist-to- hip ratio cutoffs for different ethnic groups.
Eur J Clin Nutr 2010, 64:42-61.
Mirrakhimov et al. Cardiovascular Diabetology 2012, 11:16
http://www.cardiab.com/content/11/1/16
Page 5 of 620. Lean J, Han TS, Morrison CE: Waist circumference as a measure for
indicating need for weight management. BMJ 1995, 311(6998):158-161.
21. Lean J, Han TS, Seidell JC: Impairment of health and quality of life in
people with large waist circumference. Lancet 1998, 351(9106):853-856.
22. Han TS, van Leer EM, Seidell JC, Lean J: Waist circumference action levels
in the identification of cardiovascular risk factors: prevalence study in a
random sample. BMJ 1995, 311(7017):1401-1405.
23. World Health Organization: Obesity: Preventing and Managing the Global
Epidemic: Report on a WHO Consultation (WHO Technical Report Series
894. Geneva, Switzerland: World Health Organization; 2000.
24. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE: Body composition,
visceral fat, leptin and insulin resistance in Asian Indian men. J Clin
Endocrinol Metab 1999, 84:137-144.
25. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM: Relationship
between generalized and upper body obesity to insulin resistance in
Asian Indian men. J Clin Endocrinol Metab 1999, 84:2329-2335.
26. Snehalatha C, Viswanathan V, Ramachandran A: Cutoff Values for Normal
Anthropometric Variables in Asian Indian Adults. Diabetes Care 2003,
26(5):1380-1384.
27. Mohan V, Deepa M, Farooq S, Narayan KM, Datta M, Deepa R:
Anthropometric cut points for identification of cardiometabolic risk
factors in an urban Asian Indian population. Metabolism 2007,
56(7):961-968.
28. Zhou BF: Cooperative Meta-Analysis Group of the Working Group on
Obesity in China. Predictive values of body mass index and waist
circumference for risk factors of certain related diseases in Chinese
adults: study on optimal cut-off points of body mass index and waist
circumference in Chinese adults. Biomed Environ Sci 2002, 15:83-96.
29. Examination Committee of Criteria for “Obesity Disease” in Japan; Japan
Society for the Study of Obesity. New criteria for “obesity disease” in
Japan. Circ J 2002, 66(11):987-992.
30. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al: Appropriate waist
circumference cutoff points for central obesity in Korean adults. Diabetes
Res Clin Pract 2007, 75:72-80.
31. Koh JH, Koh SB, Lee MY, Jung PM, Kim BH, Shin JY, et al: Optimal Waist
Circumference Cutoff Values for Metabolic Syndrome Diagnostic Criteria
in a Korean Rural Population. J Korean Med Sci 2010, 25:734-737.
32. Park YM, Kwon HS, Lim SY, Lee JH, Yoon KH, Son HY, et al: Optimal waist
circumference cutoff value reflecting insulin resistance as a diagnostic
criterion of metabolic syndrome in a nondiabetic Korean population
aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC)
study. Yonsei Med J 2010, 51(4):511-518.
33. Heshmat R, Khashayar P, Meybodi HR, Homami MR, Larijani B: The
appropriate waist circumference cut-off for Iranian population. Acta Med
Indones 2010, 42(4):209-215.
doi:10.1186/1475-2840-11-16
Cite this article as: Mirrakhimov et al.: Cut off values for abdominal
obesity as a criterion of metabolic syndrome in an ethnic Kyrgyz
population (Central Asian region). Cardiovascular Diabetology 2012 11:16.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mirrakhimov et al. Cardiovascular Diabetology 2012, 11:16
http://www.cardiab.com/content/11/1/16
Page 6 of 6